Pictet Asset Management Holding Sa Biocryst Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 612,324 shares of BCRX stock, worth $6.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
612,324
Previous 26,442
2215.72%
Holding current value
$6.47 Million
Previous $198,000
2219.19%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$229 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$211 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$94.3 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$91.9 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$82.5 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.96B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...